Incidence and long-term cost of steroid-related side effects after renal transplantation
Authors:
- Jennie H. BestJBJennie H. Best
- John HornbergerJHJohn Hornberger
- Sean D. SullivanSSSean D. Sullivan
- Donald E. HricikDHDonald E. Hricik
- 1 May 1999
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 33 (5) , 829-839
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Prevention of Transplant RejectionDrugs, 1997
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Cardioprotection and antihypertensive therapy: The key importance of addressing the associated coronary risk factors (the Framingham experience)The American Journal of Cardiology, 1996
- Corticosteroids in Kidney Transplant RecipientsDrug Safety, 1995
- THE EFFECT OF IMMUNOSUPPRESSIVE DRUGS ON QUALITY OF LIFE AFTER RENAL TRANSPLANTATIONTransplantation, 1995
- BONE MINERAL DENSITY AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Secular trends in stroke incidence and mortality. The Framingham Study.Stroke, 1992
- EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- POSTTRANSPLANT HYPERGLYCEMIATransplantation, 1989
- COMPLETE REPLACEMENT OF METHYLPREDNISOLONE BY AZATHIOPRINE IN CYCLOSPORINE-TREATED PRIMARY CADAVERIC RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, ILTransplantation, 1988